Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)-Reference-Cited by-同舟云学术

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)

Published:2021-03-13 Issue:4 Volume:16 Page:41-45
ISSN:1999-8627
Container-title:Tumors of female reproductive system
language:
Short-container-title:Opuholi ženskoj reproduktivnoj sistemy

Author:

Krumin Yu. S.¹^ORCID,Khaylenko V. A.²,Kozlov N. A.³,Cheremis G. Yu.³,Petrovskyy A. V.³,Khaylenko D. V.²,Artamonova E. V.³^ORCID,Kovalenko E. I.³

Affiliation:

1. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

2. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

3. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Abstract

The article analyzes data from the world literature for the period from 2005 to 2020 on the relationship between the variability of immunohistochemical expression of estrogen and progesterone receptors, HER2/neu protein and the index of proliferative activity in invasive breast cancer with the course of the disease and the response to medication.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference36 articles.

1. Global health observatory: the data repository. Geneva: World Health Organization, 2018. Available at: http://www.who.int/gho/database/en.

2. Perou C.M., Sørlie T., Eisen M.B. et al. Molecular portraits of human breast tumours. Nature 2000;406(6797):747–52. DOI: 10.1038/35021093.

3. Esteller M. Cancer epigenomics: DNA methylomes and histonemodification maps. Nat Rev Genet 2007;8:286–98. DOI: 10.1038/nrg2005.

4. Zellmer V.R., Zhang S. Evolving concepts of tumor heterogeneity. Cell Biosci 2014;5(69):1–8.

5. Curigliano G., Burstein H.J., Winer E.P. et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol 2017;28(8):1700–12. DOI: 10.1093/annonc/mdx308.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paget’s disease of the breast: a contemporary perspective;Research and Practical Medicine Journal;2023-04-05